1. A Universal Framework for the Benefit-Risk Assessment of Medicines: Is This the Way Forward?. (January 2015) Authors: Walker, Stuart; McAuslane, Neil; Liberti, Lawrence; Leong, James; Salek, Sam Journal: Therapeutic innovation & regulatory science Issue: Volume 49:Number 1(2015:Jan.) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An Evaluation of the Efficiency of the Gulf Cooperation Council's Centralized Procedure by the Gulf Regulatory Authorities and Pharmaceutical Companies: Recommendations for an Improved Model. (July 2015) Authors: Al-Rubaie, Mohamed H.; Salek, Sam; Walker, Stuart Journal: Therapeutic innovation & regulatory science Issue: Volume 49:Number 4(2015:Jul.) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing the Quality of Decision Making in the Development and Regulatory Review of Medicines: Identifying Biases and Best Practices. (March 2017) Authors: Bujar, Magdalena; Donelan, Ronan; McAuslane, Neil; Walker, Stuart; Salek, Sam Journal: Therapeutic innovation & regulatory science Issue: Volume 51:Number 2(2017:Mar.) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Benefit-risk assessment of medicines : the development and application of a universal framework for decision-making and effective communication /: the development and application of a universal framework for decision-making and effective communication. ([2015]) Editors: Leong, James; Salek, Sam; Walker, Stuart R, 1944- Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance. Issue 2 (1st February 2022) Authors: Rahalkar, Hasumati; Sheppard, Alan; Salek, Sam Journal: Expert review of clinical pharmacology Issue: Volume 15:Issue 2(2022) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices. Issue 1 (2nd January 2022) Authors: Sithole, Tariro; Salek, Sam; Mahlangu, Gugu; Walker, Stuart Journal: Expert review of clinical pharmacology Issue: Volume 15:Issue 1(2022) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease‐specific assessments. (24th February 2020) Authors: Salek, Sam; Boscoe, Audra N.; Piantedosi, Sarah; Egan, Shayna; Evans, Christopher J; Wells, Ted; Cohen, Jennifer; Klaassen, Robert J.; Grace, Rachael; Storm, Michael Journal: European journal of haematology Issue: Volume 104:Number 5(2020) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Factors influencing quality decision‐making: regulatory and pharmaceutical industry perspectives. (28th January 2015) Authors: Donelan, Ronan; Walker, Stuart; Salek, Sam Journal: Pharmacoepidemiology and drug safety Issue: Volume 24:Number 3(2015:Mar.) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Haematological malignancy: Are we measuring what is important to patients? A systematic review of quality‐of‐life instruments. (14th February 2019) Authors: Goswami, Pushpendra; Khatib, Yasmin; Salek, Sam Journal: European journal of haematology Issue: Volume 102:Number 4(2019) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Is there a need for a universal benefit–risk assessment framework for medicines? Regulatory and industry perspectives1. (5th June 2013) Authors: Leong, James; McAuslane, Neil; Walker, Stuart; Salek, Sam Journal: Pharmacoepidemiology and drug safety Issue: Volume 22:Number 9(2013:Sep.) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗